So Hee Kim
Overview
Explore the profile of So Hee Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glycoengineered stem cell-derived extracellular vesicles for targeted therapy of acute kidney injury
Kim S, Kim C, Lee C, Lee J, Kang H, Cho S, et al.
Biomaterials
. 2025 Feb;
318:123165.
PMID: 39923538
Acute kidney injury (AKI) is associated with high morbidity and mortality rates, primarily due to the lack of effective therapeutic options for kidney repair. To restore the biological function of...
2.
Jeon S, Jang J, Chakraborty S, Kim S, Oh S, Kim S, et al.
J Craniofac Surg
. 2025 Feb;
PMID: 39899803
This study aims to predict the timing of palatoplasty in infants with cleft lip and palate (CLP) using a machine learning (ML) algorithm. The study included 111 patients with nonsyndromic...
3.
Munoz F, Beigi R, Posavad C, Kelly C, Badell M, Bunge K, et al.
Pediatr Infect Dis J
. 2025 Jan;
43(11):1065-1073.
PMID: 39774938
Background: Following maternal COVID-19 vaccination, the persistence of antibodies in sera and breast milk for mothers and infants is not well characterized. We sought to describe the persistence of antibodies...
4.
Kang M, Kim S, Park J, Yeom S, Park J, Kim J
Food Sci Biotechnol
. 2025 Jan;
34(1):227-236.
PMID: 39758732
Chronic inflammation is persistent disease caused by unregulated activation of pathway and production of pro-inflammatory cytokines, induced by accumulation of reactive oxygen species above thresholds. The purpose of this study...
5.
Choi H, Park S, Bae S, Chang S, Kim S
Biomol Ther (Seoul)
. 2024 Dec;
PMID: 39667851
Tofacitinib, which is used to treat rheumatoid arthritis (RA), is primarily metabolized by the hepatic cytochrome P450 (CYP) enzymes, CYP3A1/2 and CYP2C11. Acetaminophen (APAP), which is frequently used for pain...
6.
Kim J, Kim M, Kim S, Kim S, Yu S, Hwang W, et al.
Nat Commun
. 2024 Sep;
15(1):7669.
PMID: 39227369
SeS positive electrodes are promising components for the development of high-energy, non-aqueous lithium sulfur batteries. However, the (electro)chemical and structural evolution of this class of positive electrodes is not yet...
7.
Ban J, Seo B, Yu Y, Kim M, Choe J, Park J, et al.
Drug Metab Dispos
. 2024 Aug;
52(11):1262-1270.
PMID: 39168524
In this study, the nonclinical pharmacokinetics of OLX702A-075-16, an RNA interference therapeutic currently in development, were investigated. OLX702A-075-16 is a novel -acetylgalactosamine conjugated asymmetric small-interfering RNA (GalNAc-asiRNA) used for the...
8.
Choi H, Park S, Bae S, Chang S, Kim S
Biomol Ther (Seoul)
. 2024 Aug;
32(5):601-610.
PMID: 39091013
Tofacitinib, a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis, is metabolized through hepatic cytochrome P450 (CYP), specifically CYP3A1/2 and CYP2C11. Prolonged administration of rheumatoid arthritis medications is generally...
9.
Kim S, Jee H, Park J, Bae S, Kim S, Kim E, et al.
Eur J Pharmacol
. 2024 Aug;
981:176847.
PMID: 39089463
Insomnia is one of the most common sleep disorders, affecting 10-15% of the global population. Because classical remedies used to treat insomnia have various side effects, new therapeutics for insomnia...
10.
Kim S, Roy P, Park S
Microorganisms
. 2024 Jun;
12(6).
PMID: 38930569
This study investigated the synergistic effect of combining flavourzyme, a natural enzyme, and floating electrode-dielectric barrier discharge (FE-DBD) plasma (1.1 kV, 43 kHz, N2 1.5 m/s) treatment, a non-thermal decontamination...